Polycystic kidney disease, autosomal dominant
|
[MIM 173 900, 600 666, 613 095]
(former name: adult polycystic disease)
Prevalence estimated at 1/1.000-1/2.500: it is the most common hereditary kidney diseases. The majority of cases (known as PKD1) are due to a mutation in the PKD1 gene (16p13) coding for polycystin 1; others are due to a mutation:
Cysts develop in a small percentage of nephrons from any part of the renal tubule. Radiological diagnostic criteria (so-called Ravine criteria) are: at least 2 cysts (on one kidney or a cyst in each kidney), patient under 30 years old / / 2 cysts in each kidney between 30 and 50 years old / / 4 cysts in each kidney over 59 years.
Usual form: the first symptoms appear between 30 and 40 years of age; only 20-40 % of patients progress to end-stage renal disease (dialysis).
Rare: neonatal form with oligohydramnios, large kidneys and pulmonary hypoplasia (Potter syndrome).
In childhood: often asymptomatic; sometimes high blood pressure, micro- or macroscopic hematuria, proteinuria, urinary infections, urolithiasis.
In adults:
- intracranial aneurysms: 40 % of the cases in case of PKD1 mutation: screening is recommended from the age of 15 years
- mitral valve prolapse: 20-30 %
- aortic or cervical arteries aneurysm
Non-consistant and late hepatic involvement in 70 % of patients over the age of 60 years; occasionally associated with pancreatic cysts.
Anesthetic implications:
treatment of arterial hypertension; check renal function and electrolytes; avoid attacks of hypertension (cerebral aneurysm ?)
References :
Updated: May 2021